CIA
MRNA icon

Capital Investment Advisors’s Moderna MRNA Stock Holding History

Capital Investment Advisors’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1,275
Closed -$229K – 588
2022
Q4 		$229K Buy
+1,275
New +$208K 0.01% 496
2022
Q2 		– Sell
-1,204
Closed -$207K – 584
2022
Q1 		$207K Buy
1,204
+382
+46% +$64.3K 0.01% 547
2021
Q4 		$209K Buy
822
+108
+15% +$31.6K 0.01% 555
2021
Q3 		$275K Buy
+714
New +$263K 0.01% 471

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital Investment Advisors's MRNA Position: Q1 2023 in Review

Capital Investment Advisors sold out of Moderna (MRNA) in Q1 2023, closing a stake of 1,275 shares — an estimated $229K sold.

Capital Investment Advisors first reported a position in MRNA in Q3 2021 and held it in 4 quarters. The position peaked at $275K in Q3 2021. 1,015 funds tracked by Wall St. Rank hold MRNA as of Q1 2023.

  • Capital Investment Advisors reported no remaining Moderna position as of Q1 2023 after selling out during the quarter.
  • Capital Investment Advisors sold 1,275 Moderna shares in Q1 2023, an estimated $229K.
  • Capital Investment Advisors first reported a position in Moderna in Q3 2021 and held it in 4 quarters.
  • Capital Investment Advisors's Moderna position peaked at $275K in Q3 2021.
  • 1,015 funds tracked by Wall St. Rank held Moderna as of Q1 2023.

Based on Capital Investment Advisors's 13F filing for Q1 2023, filed 10 Apr 2023.